Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Myriad Genetics, NeoGenomics, Epigenomics, More

Myriad Genetics: Nicole Lambert

Myriad Genetics has promoted Nicole Lambert to chief operating officer. Previously, Lambert headed up Myriad's oncology, women's health, and international business divisions and genetic testing laboratory operations. In her new role, Lambert will still report to Myriad CEO Paul Diaz. She will now be in charge of spearheading the company's strategic growth plans, expanding the markets for Myriad's molecular diagnostic products, and implementing operational improvements that allow the firm to better engage with patients and doctors.


NeoGenomics: David Eberhard

NeoGenomics has appointed David Eberhard as chief medical officer of Inivata, NeoGenomics' liquid biopsy-focused subsidiary. Eberhard will be in charge of the clinical and strategic development of the subsidiary's liquid biopsy tests, including the RaDaR test for minimal residual disease. He most recently served as senior medical director of oncology at Illumina and was previously the senior director of oncology development at Genomic Health, focusing on bringing the firm's OncotypeSEQ liquid biopsy test to market.


Epigenomics: Jens Ravens

Epigenomics AG appointed Jens Ravens as chief financial officer, effective Feb. 1, 2022. Ravens will also become a member of the executive board of Epigenomics, overseeing the company's financial and administrative functions. Ravens began his career at Deutsche Bank. He previously held several positions, including VP of controlling and finance and compliance and risk officer at Hermes Group. He also served as CFO and managing director of Pleon Germany and as CFO of Pleon Europe, and as finance director and member of the board of Interseroh CDI.


For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.